{"id":"https://openalex.org/W2164822993","doi":"https://doi.org/10.2105/ajph.2015.302664","title":"National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","display_name":"National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","publication_year":2015,"publication_date":"2015-06-11","ids":{"openalex":"https://openalex.org/W2164822993","doi":"https://doi.org/10.2105/ajph.2015.302664","mag":"2164822993","pmid":"https://pubmed.ncbi.nlm.nih.gov/26066931","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4504312"},"language":"en","primary_location":{"id":"doi:10.2105/ajph.2015.302664","doi":"https://doi.org/10.2105/ajph.2015.302664","is_oa":false,"landing_page_url":"https://doi.org/10.2105/ajph.2015.302664","pdf_url":null,"source":{"id":"https://openalex.org/S168049282","display_name":"American Journal of Public Health","issn_l":"0090-0036","issn":["0090-0036","0271-4353","1541-0048","2330-9687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a-star","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320277","host_organization_name":"American Public Health Association","host_organization_lineage":["https://openalex.org/P4310320277"],"host_organization_lineage_names":["American Public Health Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Public Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4504312","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008547559","display_name":"Christopher McCall Jones","orcid":"https://orcid.org/0000-0001-8598-2100","observed_orcids":["https://orcid.org/0000-0001-8598-2100"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]},{"id":"https://openalex.org/I4210088099","display_name":"National Center for Injury Prevention and Control","ror":"https://ror.org/0015x1k58","country_code":"US","type":"other","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210088099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher M. Jones","raw_affiliation_strings":["Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I1320320070","https://openalex.org/I1336377119","https://openalex.org/I4210088099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028636710","display_name":"Melinda Campopiano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]},{"id":"https://openalex.org/I4210088099","display_name":"National Center for Injury Prevention and Control","ror":"https://ror.org/0015x1k58","country_code":"US","type":"other","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210088099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda Campopiano","raw_affiliation_strings":["Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I1320320070","https://openalex.org/I1336377119","https://openalex.org/I4210088099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038652575","display_name":"Grant T. Baldwin","orcid":"https://orcid.org/0000-0003-1028-1494","observed_orcids":["https://orcid.org/0000-0003-1028-1494"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]},{"id":"https://openalex.org/I4210088099","display_name":"National Center for Injury Prevention and Control","ror":"https://ror.org/0015x1k58","country_code":"US","type":"other","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210088099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grant Baldwin","raw_affiliation_strings":["Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I1320320070","https://openalex.org/I1336377119","https://openalex.org/I4210088099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072635409","display_name":"Elinore F. McCance\u2010Katz","orcid":"https://orcid.org/0000-0002-4296-7012","observed_orcids":["https://orcid.org/0000-0002-4296-7012"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]},{"id":"https://openalex.org/I4210088099","display_name":"National Center for Injury Prevention and Control","ror":"https://ror.org/0015x1k58","country_code":"US","type":"other","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I4210088099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elinore McCance-Katz","raw_affiliation_strings":["Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christopher M. Jones is with the Office of Public Health Strategy and Analysis, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD. Melinda Campopiano is with the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD. Grant Baldwin is with the Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I1320320070","https://openalex.org/I1336377119","https://openalex.org/I4210088099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":57.4221,"has_fulltext":false,"cited_by_count":694,"citation_normalized_percentile":{"value":0.99943723,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"105","issue":"8","first_page":"e55","last_page":"e63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.828000009059906},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.746999979019165},{"id":"https://openalex.org/keywords/opioid-treatment-programs","display_name":"opioid treatment programs","score":0.9700000286102295},{"id":"https://openalex.org/keywords/state-level-disparities","display_name":"state-level disparities","score":0.7450000047683716},{"id":"https://openalex.org/keywords/substance-use-disorder-services","display_name":"substance use disorder services","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9594322443008423},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.787791907787323},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.7626674175262451},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6679523587226868},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.5201987624168396},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.49752524495124817},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.38575175404548645},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3642747700214386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19043609499931335},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006301","descriptor_name":"Health Services Needs and Demand","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D057191","descriptor_name":"Capacity Building","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058850","descriptor_name":"Opiate Substitution Treatment","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.2105/ajph.2015.302664","doi":"https://doi.org/10.2105/ajph.2015.302664","is_oa":false,"landing_page_url":"https://doi.org/10.2105/ajph.2015.302664","pdf_url":null,"source":{"id":"https://openalex.org/S168049282","display_name":"American Journal of Public Health","issn_l":"0090-0036","issn":["0090-0036","0271-4353","1541-0048","2330-9687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a-star","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320277","host_organization_name":"American Public Health Association","host_organization_lineage":["https://openalex.org/P4310320277"],"host_organization_lineage_names":["American Public Health Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Public Health","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4504312","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4504312","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Public Health","raw_type":"Text"},{"id":"pmid:26066931","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26066931","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of public health","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:aph:ajpbhl:10.2105/ajph.2015.302664_4","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10.2105/AJPH.2015.302664","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"mag:2550365551","doi":null,"is_oa":false,"landing_page_url":"https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.2015.302664","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4504312","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4504312","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Public Health","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337426","display_name":"Center for Substance Abuse Treatment","ror":"https://ror.org/03t3qg659"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W117895865","https://openalex.org/W157157778","https://openalex.org/W1266238005","https://openalex.org/W1532955057","https://openalex.org/W1565376005","https://openalex.org/W1603856484","https://openalex.org/W1604476085","https://openalex.org/W1969472300","https://openalex.org/W1970347370","https://openalex.org/W1970489996","https://openalex.org/W1974086725","https://openalex.org/W1981055174","https://openalex.org/W1987623215","https://openalex.org/W1996915186","https://openalex.org/W2003087881","https://openalex.org/W2018461713","https://openalex.org/W2025376268","https://openalex.org/W2025653942","https://openalex.org/W2029907197","https://openalex.org/W2052813313","https://openalex.org/W2057502128","https://openalex.org/W2068035436","https://openalex.org/W2069177552","https://openalex.org/W2070123858","https://openalex.org/W2088639396","https://openalex.org/W2088789920","https://openalex.org/W2089332158","https://openalex.org/W2103355133","https://openalex.org/W2104258796","https://openalex.org/W2110463564","https://openalex.org/W2111443064","https://openalex.org/W2120121499","https://openalex.org/W2121538801","https://openalex.org/W2122752332","https://openalex.org/W2122959204","https://openalex.org/W2134458339","https://openalex.org/W2137962501","https://openalex.org/W2138390518","https://openalex.org/W2144490365","https://openalex.org/W2148420159","https://openalex.org/W2154914299","https://openalex.org/W2155111039","https://openalex.org/W2156546128","https://openalex.org/W2160744884","https://openalex.org/W2167911929","https://openalex.org/W2251920574","https://openalex.org/W2300149049","https://openalex.org/W2322254177","https://openalex.org/W2546904752","https://openalex.org/W2614718630"],"related_works":["https://openalex.org/W6996907211","https://openalex.org/W2949765941","https://openalex.org/W2153080240","https://openalex.org/W3134991224","https://openalex.org/W3015431761","https://openalex.org/W4386070369","https://openalex.org/W3127596583","https://openalex.org/W7213333801","https://openalex.org/W3010243874","https://openalex.org/W2891198053"],"abstract_inverted_index":{"OBJECTIVES:":[0],"We":[1,24],"estimated":[2],"national":[3,26,95,176],"and":[4,14,19,27,51,65,103,112,116,169,175],"state":[5,28,174],"trends":[6],"in":[7,73,107],"opioid":[8,32,47,78,123],"agonist":[9],"medication-assisted":[10],"treatment":[11,39,48,101,132,167],"(OA-MAT)":[12],"need":[13,168],"capacity":[15,59,102,133,160,170],"to":[16,179],"identify":[17],"gaps":[18,165],"inform":[20],"policy":[21],"decisions.":[22],"METHODS:":[23],"generated":[25],"rates":[29,96,127],"of":[30,42,54,77,97,119,139,153,183],"past-year":[31],"abuse":[33,79,124],"or":[34,60,80,91,125,161],"dependence,":[35],"maximum":[36,98],"potential":[37,99],"buprenorphine":[38,100,131],"capacity,":[40],"number":[41,182],"patients":[43,104],"receiving":[44,105],"methadone":[45,106],"from":[46],"programs":[49],"(OTPs),":[50],"the":[52,75,117,173,181],"percentage":[53],"OTPs":[55,108,155],"operating":[56,157],"at":[57,140,150,158,172],"80%":[58,159],"more":[61],"using":[62],"Substance":[63],"Abuse":[64],"Mental":[66],"Health":[67],"Services":[68],"Administration":[69],"data.":[70],"RESULTS:":[71],"Nationally,":[72],"2012,":[74],"rate":[76],"dependence":[81,126],"was":[82],"891.8":[83],"per":[84,143],"100":[85],"000":[86],"people":[87],"aged":[88],"12":[89],"years":[90],"older":[92],"compared":[93],"with":[94],"of,":[109],"respectively,":[110],"420.3":[111],"119.9.":[113],"Among":[114],"states":[115,147],"District":[118],"Columbia,":[120],"96%":[121],"had":[122,136],"higher":[128],"than":[129],"their":[130,154],"rates;":[134],"37%":[135],"a":[137],"gap":[138],"least":[141,151],"5":[142],"1000":[144],"people.":[145],"Thirty-eight":[146],"(77.6%)":[148],"reported":[149],"75%":[152],"were":[156],"more.":[162],"CONCLUSIONS:":[163],"Significant":[164],"between":[166],"exist":[171],"levels.":[177],"Strategies":[178],"increase":[180],"OA-MAT":[184],"providers":[185],"are":[186],"needed.":[187]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":34},{"year":2023,"cited_by_count":55},{"year":2022,"cited_by_count":69},{"year":2021,"cited_by_count":99},{"year":2020,"cited_by_count":105},{"year":2019,"cited_by_count":124},{"year":2018,"cited_by_count":67},{"year":2017,"cited_by_count":61},{"year":2016,"cited_by_count":32},{"year":2015,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}